Ignite Creation Date:
2024-10-25 @ 8:02 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06526000
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-07-23
Brief Title:
Study to Assess Changes in Immunoglobulins in Patients With Relapsing Multiple Sclerosis Treated With Anti-CD20 Therapies
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Retrospective EMR Study to Assess Changes in Immunoglobulins in Patients With Relapsing Forms of Multiple Sclerosis Treated With Anti-CD20 Monoclonal Antibodies
Status:
COMPLETED
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This was an observational retrospective cohort study using electronic medical records EMRs to study immunoglobulin levels over time among patients with relapsing forms of multiple sclerosis MS newly initiating anti-CD20 monoclonal antibody treatment in clinical practice
The index date was defined as the date of anti-CD20 drug initiation during the study period The baseline period was defined as 12 months prior to the index date
The index date was defined as the date of anti-CD20 drug initiation during the study period The baseline period was defined as 12 months prior to the index date
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: